PharmaCyte Biotech (PMCB) Gross Profit (2010 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly Gross Profit of -$3333.0 for Q4 2012, down 124.14% year-over-year from $13808.0 in Q4 2011, and down 150.3% quarter-over-quarter from $6626.0 in Q3 2012.
PharmaCyte Biotech (PMCB) Gross Profit (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Gross Profit for 3 consecutive years, with -$3333.0 the latest figure, recorded in Q4 2012.
- In Q4 2012, Gross Profit fell 124.14% year-over-year to -$3333.0; the TTM figure through Jul 2013 stood at -$3333.0 (down 106.7% YoY), while the FY2013 annual figure was $2540.0, down 94.62% from the prior year.
- Gross Profit retreated to -$3333.0 in Q4 2012 per PMCB's latest filing, from $6626.0 in the prior quarter.
- Across five years, Gross Profit topped out at $50803.0 in Q2 2011 and bottomed at -$3333.0 in Q4 2012.
- Historically, Gross Profit has averaged $14436.1 across 3 years, with a median of $12117.5 in 2010.
- On a YoY basis, Gross Profit climbed as much as 79.84% in 2012 and fell as far as 124.14% in 2012.
- PharmaCyte Biotech's Gross Profit stood at $13015.0 in 2010, then gained by 6.09% to $13808.0 in 2011, then slumped by 124.14% to -$3333.0 in 2012.
- Business Quant data shows PMCB's Gross Profit at -$3333.0 in Q4 2012, $6626.0 in Q3 2012, and $11220.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -3,333.00 |
| Oct 31, 2012 | -3,333.00 |
| Jul 31, 2012 | 6,626.00 |
| Jul 31, 2012 | 6,626.00 |
| Apr 30, 2012 | 11,220.00 |
| Apr 30, 2012 | 11,220.00 |
| Jan 31, 2012 | 18,060.00 |
| Jan 31, 2012 | 18,060.00 |
| Oct 31, 2011 | 13,808.00 |
| Oct 31, 2011 | 13,808.00 |
| Jul 31, 2011 | 4,087.00 |
| Jul 31, 2011 | 4,087.00 |
| Apr 30, 2011 | 50,803.00 |
| Apr 30, 2011 | 50,803.00 |
| Jan 31, 2011 | 10,042.00 |
| Jan 31, 2011 | 10,042.00 |
| Oct 31, 2010 | 13,015.00 |
| Oct 31, 2010 | 13,015.00 |
| Jul 31, 2010 | 20,033.00 |
| Jul 31, 2010 | 20,033.00 |